Using multivariable models, the HR for prostate cancer metastasis with high FASN expression was greater than 1 for patients with high BMI, but less than 1 for patients with low BMI, though FASN expression level was not statistically significant in either model (Supplementary Table S7). Here, FASN is linked to prostate carcinoma.